文献速递肝胆胰外科胃肠外科

晚期胆囊癌大范围肝切除及联合手术的指征

Indications for major hepatectomy and combined procedures for advanced gallbladder cancer.
PubMed 文献 · Br J Surg · 2016-11-16

该研究纳入96例II-IV期胆囊癌切除患者,比较大范围肝切除(29例)与小范围肝切除(67例)及不可切除组(15例)的结局。亚组分析中肝转移和肝动脉侵犯与生存独立相关,且这两类患者生存与不可切除组相当。

要点

  • 肝转移或肝动脉侵犯者生存与不可切除组相当,应慎重选择大范围肝切除。

核心结论

  • 晚期胆囊癌可考虑大范围肝切除联合门静脉切除或胰十二指肠切除术,尤其适用于无肝转移或肝动脉侵犯的选定患者。

研究设计与样本

  • 研究纳入96例接受手术切除的II、III或IV期胆囊癌患者,其中29例行大范围肝切除,67例行小范围肝切除,另15例为不可切除胆囊癌。

主要发现

  • 大范围肝切除组无术后死亡。

临床怎么用

  • 对晚期胆囊癌,大范围肝切除联合门静脉切除或胰十二指肠切除术可考虑用于无肝转移或肝动脉侵犯的选定患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical impact of major hepatectomy for advanced gallbladder cancer is currently unclear. METHODS: Patients who underwent resection for stage II, III or IV gallbladder cancer were enrolled. The surgical outcomes of patients who underwent major hepatectomy were compared with those of patients treated with minor hepatectomy and those with unresectable gallbladder cancer. The clinical impact of major hepatectomy and combined advanced procedures such as portal vein resection or pancreatoduodenectomy for advanced gallbladder cancer were evaluated. RESULTS: A total of 96 patients were enrolled; 29 patients underwent major and 67 had minor hepatectomy. The overall morbidity rate was higher in the major hepatectomy group (55 versus 27 per cent; P = 0·022). There were no deaths after major hepatectomy. Overall survival was better in the major hepatectomy group than in the group of 15 patients with unresectable disease (median survival 17·7 versus 11·4 months; P = 0·003). In a subgroup analysis of the major hepatectomy group, liver metastasis (P = 0·038) and hepatic arterial invasion (P = 0·017) were independently associated with overall survival. Overall survival in patients with liver metastasis (P = 0·572) or hepatic arterial invasion (P = 0·776) was comparable with that in the unresectable group. However, overall survival among patients with lymph node metastasis (P = 0·062) or following portal vein resection (P = 0·054) or pancreatoduodenectomy (P = 0·011) was better than in the unresectable group. CONCLUSION: Major hepatectomy combined with portal vein resection or pancreatoduodenectomy, if necessary, may be considered in the treatment of advanced gallbladder cancer, especially in selected patients without liver metastasis or hepatic arterial invasion.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Yamamoto Y, Sugiura T, Ashida R, et al. Indications for major hepatectomy and combined procedures for advanced gallbladder cancer. Br J Surg. 2016. PMID: 27864927. doi:10.1002/bjs.10401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。